Holly Butler

Roche Diagnostics Corp. develops and manufactures diagnostic products. It offers anticoagulation management, blood gas and electrolytes, cholesterol and urinalysis products. The firm provides a broad portfolio of tools that help healthcare providers in the prevention, diagnosis and management of diseases like HPV, HIV, heart failure and diabetes, as well as other medical conditions, such as fertility and blood coagulation. Its products and services uses by researchers, physicians, patients, hospitals and laboratories worldwide. The company was founded in 1964 by Willard Eason and is headquartered in Indianapolis, IN.

Oxford Immunotec Ltd. operates as a medical diagnostic company. It develops and sells medical diagnostic products. The company was founded by Peter Wrighton-Smith in 2002 and is headquartered in Abingdon, the United Kingdom.

Cardiac Science Corp. develops, manufactures, and markets Powerheart automated external defibrillators. Its offers power heart AED G5, G5 trainer, G3 plus, G3 Pro, G3 trainer, and rescue ready services. The company was founded in 1913 and is headquartered in Waukesha, WI.

Roche Molecular Systems, Inc. develops and produces molecular-based diagnostic tests and automated testing platforms. It specializes in oncology, virology, microbiology and blood screening tests areas. The firm's customers include researchers, physicians, patients, hospitals, laboratories and blood banks. The company is headquartered in Pleasanton, CA.

Abbott Diagnostics, Inc. develops, manufactures and sells medical diagnostic instrument, test and automation products. The company is headquartered in Santa Clara, CA.

Life Technologies Corp. provides products in the areas of scientific research, genetic analysis and applied sciences. Its brands include Invitrogen, Applied Biosystems, Gibco, Molecular Probes, Noves, Ambion and Ion Torrent. The firm’s portfolio includes the most cited products and technologies in qPCR, capillary electrophoresis sequencing, nextgeneration sequencing, molecular diagnostics, forensics, cell culture and analysis, and agriculture research. The company was founded on November 21, 2008 and is headquartered in Carlsbad, CA.

Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA.

Orion Health Ltd. provides clinical workflow and integration technology for the healthcare sector. Its clinical information software meets the needs of clinical staff and healthcare managers, delivering secure, universal access to healthcare information and helping healthcare providers proactively manage and coordinate patient care across the community. The company was founded by Ian Richard McCrae in 1993 and is headquartered in Auckland, New Zealand.

Quest Diagnostics TB LLC develops and sells clinical diagnostic products. It focused on developing proprietary tests for the management of immune-regulated conditions. The company was founded by Dr. Peter Wrighton-Smith in 2002 and is headquartered in Malborough, MA.

Insight Genetics, Inc. engages in the diagnosis, monitoring, and treatment of cancer. It specialize in the discovery, development, and commercialization of companion diagnostics. The company was founded in 2007 and is headquartered in Nashville, TN.

GE Healthcare, Inc. manufactures and distributes diagnostic imaging agents and radiopharmaceuticals for imaging modalities that are used in medical imaging procedures. It offers dyes that are used in magnetic-resonance-imaging procedures. The firm also manufactures medical diagnostic equipment including CT image machines. It develops healthcare technological solutions for medical imaging and information technologies, medical diagnostics, patient monitoring systems, disease research, drug discovery and biopharmaceutical manufacturing. The company was founded in 1994 and is headquartered in Princeton, NJ.

Cellmax, Inc. provides research and clinical testing services. It develops non-invasive, accurate blood tests for early detection of cancer. The company was founded by Atul Sharan and Ying-Chih Chang in 2013 and is headquartered in Sunnyvale, CA.

CancerLinQ LLC is a real-world oncology data platform developed by ASCO that collects and aggregates longitudinal electronic health record data from oncology practices throughout the world. The non-profit company is based in Alexandria, VA. The platform aims to improve the quality of patient care and accelerate discovery by securely compiling, harmonizing, analyzing, and de-identifying vast amounts of information on patient characteristics, treatments, and long-term side effects. By using data from nearly 7 million patient records in near real-time, CancerLinQ can improve health outcomes for all patients with cancer and advance evidence-based research. The company was founded in 2014. The CEO is Sean Khozin.

Twinstrand Biosciences, Inc. develops technologies to detect ultra-rare variants. It uses technology for new generation of clinical diagnostics and tools for scientific discovery. The company was founded by Jesse Salk and Michael Schmitt in 2015 and is headquartered in Seattle, WA.

EOS Syndicate Management is an independent venture capital firm founded in 2014 by Kevin Grainger. The firm is headquartered in Scotland, United Kingdom.

Chromacity Ltd. designs, manufactures and supplies ultrafast fibre lasers. Its products include spark 1040, OPO, FIR and custom systems. The firm’s applications include life sciences, security and defence, environmental sensing and fundamental research. The company was founded by Christopher Leburn, Derryck Reid and Carl Farrell in 2013 and is headquartered in Riccarton, the United Kingdom.

The Bethesda Group Fund invests in companies located in US. The fund target companies operating in the fields of Precision Medicine, Digital Health and Molecular Diagnostics. It provides financing for both early and growth stage capital requirements.

Cumulus Oncology Ltd. develops oncology drugs. The company was founded by Clare Wareing on November 13, 2017 and is headquartered in Edinburgh, the United Kingdom.

SimBioSys, Inc. (Illinois) is a computational oncology company. It transforms cancer care and precision medicine with predictive computational tools. Its concepts include tumor virtualization, computation oncology, and assessment, and analytics. The company was founded by Joseph R. Peterson in 2018 and is headquartered in Champaign, IL.